Jennison Associates LLC Cytokinetics Inc Transaction History

Jennison Associates LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 01, 2022	BUY	$38.54 - $54.52 $553,357 - $782,798	14,358 New	14,358 $696,000
Q4 2020 Feb 05, 2021	SELL	$15.26 - $28.61 $4.13 Million - $7.74 Million	-270,382 Closed	0 $0
Q3 2020 Nov 04, 2020	SELL	$20.58 - $28.96 $7.14 Million - $10 Million	-346,801 Reduced 56.19%	270,382 $5.85 Million
Q2 2020 Aug 06, 2020	BUY	$11.15 - $24.64 $33,773 - $74,634	3,029 Added 0.49%	617,183 $14.5 Million
Q1 2020 May 06, 2020	BUY	$8.75 - $16.3 $36,662 - $68,297	4,190 Added 0.69%	614,154 $7.24 Million
Q4 2019 Feb 07, 2020	BUY	$7.95 - $11.84 $4.85 Million - $7.22 Million	609,964 New	609,964 $6.47 Million

407

125M

4.6M

2.43M

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.31B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

Stay updated on Jennison Associates LLC with notifications on news.